REG - Walker Crips Group - Trading Update

Walker CripsAnnouncement

26/02/2019 16:00

RNS Number : 1861R
Walker Crips Group plc
26 February 2019
 


The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
 
26 February 2019
 
Walker Crips Group plc
 
("Walker Crips", the "Company" or the "Group")
 
Trading Update
 
Walker Crips Group plc, the national investment and wealth management group, provides the following trading update.
In the Group's interim results for the period to 30 September 2018, announced on 27 November 2018, Walker Crips advised that, despite the disappointing results for the first half, the Group's programme for implementing change through the introduction of new revenue streams and cost savings should provide the platform for an improved second half performance.
The Group continues to implement this renewed strategy, however, the ongoing political and economic uncertainty surrounding the UK's exit from the EU and nervousness in the market remains a significant factor, affecting both the level of volume-driven broking commission earned and the intended launch date of planned new initiatives. As a result of the continued challenging market conditions, the Group expects the full year performance to be much lower than the reported results for the prior year to 31 March 2018.
The Group will report its full year results in July 2019.
 
For further information contact:
 
Walker Crips Group plc                                                +44 (0) 20 3100 8000
Bridgette Campbell, Media Relations
 
Cantor Fitzgerald Europe                                              +44 (0) 20 7894 7000
Will Goode / Philip Davies
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSEIFIMFUSEIE